rolipram has been researched along with Obstructive Lung Diseases in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Using a rat model of lipopolysaccharide (LPS)-induced pulmonary inflammation, the antiinflammatory activity of SB 207499 was evaluated and compared to that of the prototypic type-4 phosphodiesterase (PDE4) inhibitor, rolipram." | 3.71 | Comparison of PDE 4 inhibitors, rolipram and SB 207499 (ariflo), in a rat model of pulmonary neutrophilia. ( Chapman, R; Fine, J; Jones, H; Kreutner, W; Kung, TT; Minnicozzi, M; Spond, J, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rickards, KJ | 2 |
| Page, CP | 2 |
| Lees, P | 2 |
| Gettinby, G | 1 |
| Cunningham, FM | 2 |
| Dal Piaz, V | 1 |
| Giovannoni, MP | 1 |
| Spond, J | 1 |
| Chapman, R | 1 |
| Fine, J | 1 |
| Jones, H | 1 |
| Kreutner, W | 1 |
| Kung, TT | 1 |
| Minnicozzi, M | 1 |
1 review available for rolipram and Obstructive Lung Diseases
| Article | Year |
|---|---|
Phosphodiesterase 4 inhibitors, structurally unrelated to rolipram, as promising agents for the treatment of asthma and other pathologies.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Arthritis, Rheumatoid; Asthma; Cyclic Nucleotide Phosphodiester | 2000 |
3 other studies available for rolipram and Obstructive Lung Diseases
| Article | Year |
|---|---|
In vitro and ex vivo effects of the phosphodiesterase 4 inhibitor, rolipram, on thromboxane production in equine blood.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Res | 2003 |
Comparison of PDE 4 inhibitors, rolipram and SB 207499 (ariflo), in a rat model of pulmonary neutrophilia.
Topics: Adrenalectomy; Animals; Cyclohexanecarboxylic Acids; Disease Models, Animal; Humans; Inflammation; I | 2001 |
Differential inhibition of equine neutrophil function by phosphodiesterase inhibitors.
Topics: Animals; Cell Adhesion; Cells, Cultured; Horse Diseases; Horses; Lung Diseases, Obstructive; Neutrop | 2001 |